ASTROTECH Corp Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain
ASTROTECH Corp (ASTC) had Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain of $2.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain · last filed 2017-09-18
- 2017-03-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $2.00K.
- 2016-12-31: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $2.00K.
- 2016-09-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $10.00K.
- 2016-06-30: Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain $18.00K.
| Period end | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain |
|---|---|
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.00K 10-Q · filed 2017-02-13 |
| 2016-09-30 | $10.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $18.00K 10-K · filed 2017-09-18 |
| 2016-03-31 | $10.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $1.00K 10-Q · filed 2016-02-10 |
| 2015-09-30 | $10.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $11.00K 10-K · filed 2016-09-29 |
| 2015-03-31 | $8.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |